Artificial liver support devices for fulminant liver failure (Q33949286)

30 July 2017

1 reference

title

Artificial liver support devices for fulminant liver failure (English)

1 reference

30 July 2017

1 reference

Sechser A

1

1 reference

30 July 2017

Osorio J

series ordinal

2

1 reference

30 July 2017

Freise C

series ordinal

3

1 reference

30 July 2017

Osorio RW

series ordinal

4

1 reference

30 July 2017

publication date

1 May 2001

1 reference

30 July 2017

published in

Clinics in liver disease

1 reference

30 July 2017

volume

5

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

415-430

1 reference

Long-term hepatic support by intermittent multi-species liver perfusions

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: a pre-clinical controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Assay to detect inhibitory substances in serum of patients with acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Liver assist systems: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Liver transplantation for fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Fulminant hepatic failure: pathophysiology, treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Reconstruction of liver tissue in vitro: geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

What should we expect from a bioartificial liver in fulminant hepatic failure?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

The Application of Immobilized Enzymes in an Artificial Liver Support System

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Acute Hepatic Coma Treated by Cross-Circulation or Exchange Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Microencapsulated hepatocytes for bioartificial liver support

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Characterization of possible "toxic" metabolites in uremia and hepatic coma based on the clearance spectrum for larger molecules by the ACAC microcapsule artificial kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Clinical experience with a porcine hepatocyte-based liver support system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Total blood washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Bioartificial liver based on porcine hepatocyte: in vitro functional assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Hepatocyte transplantation. A potential treatment for liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

New method of hepatocyte transplantation and extracorporeal liver support

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Soluble Liver Extract as Supplement to Detoxification by Hemoperfusion in Liver Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Development of a bioartificial liver using isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Loss and recovery of liver regeneration in rats with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Heterologous liver perfusion in treatment of hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Plasmapheresis in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Charcoal haemoperfusion in the treatment of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Earlier charcoal haemoperfusion in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

A treatment system for implementing an extracorporeal liver assist device

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Extracorporeal liver assist devices in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Substance P is markedly increased in plasma of patients with hepatic coma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Clinical experience with charcoal and resin hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Artificial liver support in acute liver failure: a review of studies at King's.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Is the biological artificial liver clinically applicable? A historic review of biological artificial liver support systems

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Ammonia intoxication treated by hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Removal of blood ammonia by hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

High volume plasma exchange in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Reversal of experimental acute hepatic failure in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

The effect of gamma-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Role of transport proteins in bioartificial liver assist systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Bilirubin removal from an hepatic failure patient by resin hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Removal of endotoxin and cytokines by adsorbents and the effect of plasma protein binding

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Isolation and culture of porcine hepatocytes for artificial liver support.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Evolution of the bioartificial liver: the need for randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Early indicators of prognosis in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

High-Permeability Membrane Hemodialysis and Hernofiltration in Acute Hepatic Coma: Experimental and Clinical Results

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Controlled trial of exchange-transfusion therapy in fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Development of a hybrid bioartificial liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Isolated hepatocytes in a bioartificial liver: A single group view and experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

A bioartificial liver to treat severe acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Acute hepatic coma treated by cross-circulation with a baboon and by repeated exchange transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Extracorporeal assist of anhepatic animals with liver slice perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Reversal of fulminant hepatic failure using an extracorporeal liver assist device

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

The Hepatix extracorporeal liver assist device: initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Does a porcine hepatocyte hybrid artificial liver prolong the survival time of anhepatic rabbits?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Artificial liver. State of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Treatment of Hepatic Coma by Exchange Blood Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970172-0

7 January 2021

10.1016/S1089-3261(05)70172-0

Identifiers

DOI

1 reference

30 July 2017

1 reference